Morning Edition: Juno acquires biotech; Partners HQ; OT violations; Five Things to Know

July 15, 2016 - A LOOK AT THE DAY'S BUSINESS STORIES FROM MEDIA OUTLETS AROUND BOSTON

COMPANIES IN TODAY'S MORNING EDITION

TRENDS & TOPICS IN TODAY'S MORNING EDITION

​Small biotech founded by Northeastern professor acquired for $10M plus earnouts

A small, privately held biotech founded by a professor at Northeastern University has been sold to Seattle cancer drug developer Juno Therapeutics for $10 million not including earnouts.

Partners HealthCare is still based in Boston — for now

Partners HealthCare this week unveiled its 825,000-square-foot, $465 million administrative office in Somerville's Assembly Row, but the health care system still leases an office at Boston's Prudential Center.

Mass. manufacturer, staffing agency must pay $1.4M for OT violations

The company allegedly failed to pay hundreds of workers time and a half for time worked above 40 hours a week.

Five things you need to know today, and a business case for Pokemon Go

Happy Friday, Boston. If you're not too busy chasing Pokemon characters, check out these five things to know as you start your busy business day.

Read Morning Edition >>

The inside story behind Boston Private's public struggles

MIT researchers, tech leaders take on Donald Trump in open letter

Roxbury firm proposes $47M mixed-use project near Dudley Square

CFO of the Year 2016: DiLorenzo named F. Gorham Brigham Lifetime Achievement award winner

Why Shire is expecting its pending drug launch to be a blockbuster

These Boston outfits rank among the best law firms to work

Read Morning Edition >>

Contact Us
Contact Us For all inquiries regarding this offer or subscription to the Boston Business Journal, please email us at: [email protected]

Cancel Email Subscription
To unsubscribe from this email - click here

If you need other assistance, please let us know or contact:
bizjournals customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202.

© 2016 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.